ClinicalTrials.gov record
Recruiting Phase 3 Interventional

A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the Treatment of Schizophrenia and Autism-Related Irritability in Adolescents, Respectively

ClinicalTrials.gov ID: NCT07424404

Public ClinicalTrials.gov record NCT07424404. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 11:20 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3 Multicenter, Open-label Study to Assess the Long-term Safety and Tolerability of KarXT in Adolescents (13 to 17 Years of Age) With Schizophrenia and KarXT+KarX-EC in Children and Adolescents (5 to 17 Years of Age) With Irritability Associated With Autism Spectrum Disorder

Study identification

NCT ID
NCT07424404
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Industry
Enrollment
400 participants

Conditions and interventions

Interventions

  • KarXT Drug

Drug

Eligibility (public fields only)

Age range
5 Years to 17 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 6, 2026
Primary completion
Mar 7, 2030
Completion
Mar 7, 2030
Last update posted
May 10, 2026

2026 – 2030

United States locations

U.S. sites
19
U.S. states
11
U.S. cities
19
Facility City State ZIP Site status
Local Institution - 0077 Anaheim California 92805 Not yet recruiting
Local Institution - 0058 Chino California 91710 Not yet recruiting
Local Institution - 0024 Culver City California 90230 Not yet recruiting
Local Institution - 0083 Redlands California 92373 Not yet recruiting
Local Institution - 0089 San Francisco California 94158 Not yet recruiting
Apg Research, Llc Orlando Florida 32803 Recruiting
Atlanta Center for Medical Research Atlanta Georgia 30331 Recruiting
Salveo Integrative Health - Lawrenceville Lawrenceville Georgia 30046 Recruiting
Local Institution - 0039 Stone Mountain Georgia 30083 Not yet recruiting
EmVenio Research Center - Prime Healthcare Chicago Illinois 60622 Recruiting
Local Institution - 0076 Boston Massachusetts 02115 Not yet recruiting
Local Institution - 0059 Worcester Massachusetts 01608 Not yet recruiting
Local Institution - 0061 Great Neck New York 11021 Not yet recruiting
University of Cincinnati Cancer Institute Cincinnati Ohio 45219 Recruiting
Local Institution - 0097 Philadelphia Pennsylvania 19139 Not yet recruiting
Local Institution - 0137 Nashville Tennessee 37212 Not yet recruiting
Local Institution - 0046 Garland Texas 75043 Not yet recruiting
Local Institution - 0066 Spring Texas 77381 Not yet recruiting
Local Institution - 0050 Richmond Virginia 23284 Not yet recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 40 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07424404, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 10, 2026 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07424404 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →